Omeros presents clinical data of OMS302 on reducing pupil constriction during ILR at ASCRS meeting
Omeros Corporation today reported analyses of Phase 2 and Phase 3 clinical data showing the favorable impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement.